Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 8;24(1):111.
doi: 10.1186/s12888-024-05538-0.

Impact of post-COVID-19 olfactory disorders on quality of life, hedonic experiences and psychiatric dimensions in general population

Louise-Emilie Dumas  1   2 , Clair Vandersteen  3   4 , Victoria Metelkina-Fernandez  3   5 , Auriane Gros  3   6 , Philippe Auby  7   3 , Florence Askenazy-Gittard  7   3
Affiliations

Impact of post-COVID-19 olfactory disorders on quality of life, hedonic experiences and psychiatric dimensions in general population

Louise-Emilie Dumas et al. BMC Psychiatry. .

Abstract

Background and objective: Olfactory disorders in COVID-19 impact quality of life and may lead to psychological impairments. Prevalence ranges from 8 to 85%, persisting in about 30% of cases. This study aimed to evaluate the 6-month post-COVID-19 impact on quality of life, hedonic experiences, anxiety and depression due to olfactory disorders. Additionally, it sought to compare psychophysical tests and self-perceived olfactory evaluations.

Methods: A prospective, longitudinal study was conducted over baseline (T0) and 6 months (T1) on individuals with persistent olfactory disorders post-COVID-19 for more than 6 weeks. Psychophysical tests employed the Sniffin' Sticks Test® (TDI score), and self-perceived olfactory evaluation used a Visual Analogue Scale. Quality of life was assessed with an Olfactive Disorder Questionnaire and the French version of the Quality of Life and Diet Questionnaire. Hedonic experiences were gauged using the Snaith-Hamilton Pleasure Scale, while anxiety and depression dimensions were measured by The State-Trait Anxiety Inventory, The Post Traumatic Stress Checklist Scale, and Hamilton Rating Scale for Depression. Participants were classified into the "normosmic group" (NG) and the "olfactory disorders group" (ODG) at T0 and T1 based on the TDI score.

Results: Were included 56 participants (58.93% women, 41.07% men) with a mean age of 39.04 years and a mean duration of post-COVID-19 olfactory disorders of 5.32 months. At T1, ODG had a significantly lower quality of life and hedonic experiences than NG. No significant differences in anxiety and depression dimensions were observed between groups. At T0, psychophysical tests and self-perceived olfactory evaluations were significantly correlated with quality of life and hedonic experiences in both groups. At T1, self-perceived olfactory evaluation in NG correlated significantly with quality of life, hedonic experiences, anxiety and depression dimensions, whereas ODG only correlated with hedonic experiences.

Conclusion: Individuals with persistent post-COVID-19 olfactory disorders after six months demonstrated compromised quality of life and hedonic experiences. Self-perceived olfactory evaluation played a more significant role in influencing quality of life and the dimension of anxiety and depression than the psychophysical presence of olfactory disorders. These findings emphasize the importance of considering patients' perceptions to comprehensively assess the impact of olfactory disorders on their well-being.

Trial registration: ClinicalTrials.gov number (ID: NCT04799977).

Keywords: Cognition; Covid-19; Emotion; Hedonic experiences (8 words); Odor perception; Olfactory disorders; Psychiatric; Psychopathology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Organisation Mondial de la Santé. Maladie à coronavirus 2019 (COVID-19): ce qu’il faut savoir [Internet]. 2021 [cited 2023 Mar 9]. Available from: https://www.who.int/fr/news-room/questions-and-answers/item/coronavirus-....
    1. Brandão Neto D, Fornazieri M, Dib C, Di Francesco R, Doty R, Voegels R et al. Chemosensory Dysfunction in COVID-19: Prevalences, Recovery Rates, and Clinical Associations on a Large Brazilian Sample. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg [Internet]. 2021 Mar [cited 2023 Mar 9];164(3). Available from: https://pubmed.ncbi.nlm.nih.gov/32867582/. - PMC - PubMed
    1. Costa KVT da, Carnaúba ATL, Rocha KW, de Andrade KCL, Ferreira SMS, Menezes P. de L. Olfactory and taste disorders in COVID-19: a systematic review. Braz J Otorhinolaryngol [Internet]. 2020; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280089/. - PMC - PubMed
    1. Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: A systematic review. Wellcome Open Res [Internet]. 2020;5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308993/. - PMC - PubMed
    1. Moein S, Hashemian S, Tabarsi P, Doty R. Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients. Int Forum Allergy Rhinol [Internet]. 2020 Oct [cited 2023 Mar 9];10(10). Available from: https://pubmed.ncbi.nlm.nih.gov/32761796/. - PMC - PubMed

Associated data